De novo designed KABLE protein
Correy, G.J., Fraser, J.S.To be published.
Experimental Data Snapshot
Starting Model: in silico
View more details
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| De novo designed KABLE protein | 127 | synthetic construct | Mutation(s): 0  | ![]() | |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 3 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| 3NY (Subject of Investigation/LOI) Query on 3NY | B [auth A], C [auth A], D [auth A] | 5-nitro-1H-benzotriazole C6 H4 N4 O2 AOCDQWRMYHJTMY-UHFFFAOYSA-N | |||
| CAC Query on CAC | E [auth A] | CACODYLATE ION C2 H6 As O2 OGGXGZAMXPVRFZ-UHFFFAOYSA-M | |||
| ZN Query on ZN | F [auth A], G [auth A], H [auth A], I [auth A] | ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 44.601 | α = 90 |
| b = 44.601 | β = 90 |
| c = 128.033 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| XDS | data scaling |
| XDS | data reduction |
| PHASER | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) | United States | GM145238 |